HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
glycylproline 4-nitroanilidase
splits of glycylproline from p-nitroaniline
Also Known As:
GPNAase; glycylproline p-nitroanilidase
Networked:
5
relevant articles (
0
outcomes,
0
trials/studies)
Bio-Agent Context: Research Results
Enzymes and Coenzymes: 1
Enzymes: 152586
Hydrolases: 2166
Peptide Hydrolases: 23957
Exopeptidases: 68
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases: 379
glycylproline 4-nitroanilidase: 5
Related Diseases
1.
Rheumatoid Arthritis
07/01/1978 - "
Serum glycylproline p-nitroanilidase activity in rheumatoid arthritis.
"
08/15/1978 - "
Glycylproline p-nitroanilidase activity in serum of patients with advanced rheumatoid arthritis or with systemic lupus erythematosus but with normal hepatic function was found to be significantly lower than that of normal adult controls.
"
08/15/1978 - "
Serum glycylproline p-nitroanilidase activity in rheumatoid arthritis and systemic lupus erythematosus.
"
2.
Essential Hypertension
01/17/1977 - "
Glycylproline p-nitroanilidase activity in serum from patients with essential hypertension was significantly higher than that from normotensive healthy subjects.
"
07/01/1979 - "
We have studied serum glycyl-prolyl-p-nitroanilidase (GPNAase) activity and its distribution in various parts of the body in patients with acute myocardial infarction, chronic ischemic heart disease, valvular heart disease with or without congestive heart failure and essential hypertension.
"
3.
Hematologic Neoplasms (Hematological Malignancy)
12/01/1977 - "
Serum glycylproline p-nitroanilidase activity in blood cancers.
"
4.
Myocardial Ischemia (Ischemic Heart Diseases)
07/01/1979 - "
We have studied serum glycyl-prolyl-p-nitroanilidase (GPNAase) activity and its distribution in various parts of the body in patients with acute myocardial infarction, chronic ischemic heart disease, valvular heart disease with or without congestive heart failure and essential hypertension.
"
5.
Myocardial Infarction
07/01/1979 - "
Serum GPNAase activity in patients with acute myocardial infarction was significantly lower as long as 12 days after the onset as compared with normal controls.
"
07/01/1979 - "
We have studied serum glycyl-prolyl-p-nitroanilidase (GPNAase) activity and its distribution in various parts of the body in patients with acute myocardial infarction, chronic ischemic heart disease, valvular heart disease with or without congestive heart failure and essential hypertension.
"